Earnings Call · Q3 FY2024·2024-11-06

Q3 24EPS -63.64%·Rev n/aQ2 24EPS 0.00%·Rev n/aQ1 24EPS -37.50%·Rev n/aQ4 23EPS -71.43%·Rev n/a⚠ consensus missing

Evolus, Inc. EOLS

Nareg Sagherian — Investor Relations

David Moatazedi — President and Chief Executive Officer

Rui Avelar — Chief Medical Officer

Sandra Beaver — Chief Financial Officer

−15.0%1d on move date−15.8% vs SPY3d−22.0%5d−27.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EOLS calls or request research access.

More EOLS calls Browse calls Request research access